"Chemokine CCL20" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR6 RECEPTORS. It has activity towards DENDRITIC CELLS; T-LYMPHOCYTES; and B-LYMPHOCYTES.
| Descriptor ID |
D054418
|
| MeSH Number(s) |
D12.644.276.374.200.110.880 D12.644.276.374.200.600.880 D12.776.467.374.200.110.880 D12.776.467.374.200.600.880 D23.125.300.110.880 D23.125.300.600.880 D23.469.200.110.880 D23.469.200.600.880 D23.529.374.200.110.880 D23.529.374.200.600.880
|
| Concept/Terms |
Chemokine CCL20- Chemokine CCL20
- CCL20, Chemokine
- Exodus-1 Chemokine
- Chemokine, Exodus-1
- Exodus 1 Chemokine
- Small Inducible Cytokine A20
- MIP-3-alpha
- SCYA20 Chemokine
- Chemokine, SCYA20
- CCL20 Chemokine
- Chemokine, CCL20
- Macrophage Inflammatory Protein 3 alpha
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL20".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL20".
This graph shows the total number of publications written about "Chemokine CCL20" by people in this website by year, and whether "Chemokine CCL20" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CCL20" by people in Profiles.
-
SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci Rep. 2021 08 19; 11(1):16814.
-
Enrichment of CCR6+ CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19. Eur J Immunol. 2021 06; 51(6):1535-1538.
-
Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19. Sci Rep. 2020 11 16; 10(1):19839.
-
Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19. Bioessays. 2021 02; 43(2):e2000232.
-
Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation. Int J Mol Sci. 2020 Jul 31; 21(15).
-
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon ? and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. J Infect Dis. 2019 07 31; 220(5):830-840.
-
Circulating inflammation-related markers and advanced gastric premalignant lesions. J Gastroenterol Hepatol. 2019 May; 34(5):852-856.
-
CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer. Exp Cell Res. 2018 11 15; 372(2):168-177.
-
CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury. J Pathol. 2018 10; 246(2):191-204.
-
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 2018 07; 16(7):e2005869.